Administration of combined GH/IGF-1 therapy to patients with traumatic brain injury sustained improvement in metabolic and nutritional endpoints while avoiding uncontrolled infections and septic shock observed with higher GH doses in critically ill patients [90]. The gene discussed is GH1; the disease is injury.